REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/17/2026
Back to search
Official data from USPTO
Q QUIDEL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000086088768Class
1, 5, 9, 10, 42
Filing
86088768
Registration
5124615
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
67
Latest update
01/18/2026
Trademark type
Combined
Nice classes
1, 5, 9, 10, 42
Filing date
10/10/2013
Registration date
01/17/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/15/2023
Last transaction
01/18/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2013-12-00
First use in commerce
2013-12-00
Drawing code
5
Owner type
03
Owner location
RARITAN, NJ
Examiner
ESTRADA,LINDA M
Law office
L40
Current location
TMEG LAW OFFICE 104
Mark description
The mark consists of a stylized letter "Q" with the word "QUIDEL" appearing below.
Holders and representatives
Holders
ORTHO-CLINICAL DIAGNOSTICS, INC.
Q. C. (pessoa física)
Representatives
Alexis Crawford Douglas K&L Gates LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic reagent test kits comprised of monoclonal antibodiesbuffersreagents for clinical or medical laboratoryscientific or research use; diagnostic reagent test kits comprising customized microscopy slidesdetection and identification staining reagentsassociated quality control reagentsfor clinical or laboratory use
Class 5
In vitro medical diagnostic test kits for clinicalprofessionalmedical or consumer use consisting primarily of reagents together with test equipment in the nature of a medical testing device for monitoring conditions and diagnosing disease; chemicalbiochemical and biological preparations for medical use in cassette formfor use in measuringtesting and analyzing blood and other bodily fluids; chemical reagents in cassette form for medical purposesfor use in connection with diagnostic test kits for the detection of a wide variety of diseasesconditionsdisorders; diagnostic reagent test kits comprising customized microscopy slidesdetection and/or identification staining reagentsassociated quality control reagentsfor medical use
Class 9
Automated molecular diagnostic instrument for clinical laboratory use in detecting pathogens; clinical laboratory analyzers for measuringtesting and analyzing blood and other bodily fluids; automated fluorescent-based microscopy system comprising light-emitting diodes (LED)objective lensdigital camera charge-coupled device (CCD)motorized slide carrierdiagnostic software for data reduction; wireless routers; gateway routers in the nature of computer control hardware; computer software for capturingorganizingreportingmanagement of medical information and data
Class 10
Devices in the nature of glass slidescupsbags for the collection of bodily excretions and fluids from humans for medical diagnostic purposes; devices in the nature of glass slidescupsbags and test components in the nature of medical testing devices sold as a kit for the collectionpreservation and shipment of bodily excretions and fluids from humans for clinical medical diagnostic purposes; medical diagnostic apparatus comprised of an optics windowa port for a reagent testan illuminating devicespecifically adapted for reading in vitro medical test results; medical diagnostic analyzers for measuringtesting and analyzing blood and other bodily fluids
Class 42
Providing a website portal featuring technology that allows users to access medical information and data; providing temporary use of on-line non-downloadable cloud computing software for capturingorganizingreportingremote management of medical information and data
Publications
History of USPTO decisions and trademark events.
67 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
09/10/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/14/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/26/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/26/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/26/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/26/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/26/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/15/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/15/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/15/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/03/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/03/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/03/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/03/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/03/2023
E815
TEAS SECTION 8 & 15 RECEIVED
12/15/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/22/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/17/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/04/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/04/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/04/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/16/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/16/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/16/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/16/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/16/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
01/17/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/13/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/10/2016
EEXT
SOU TEAS EXTENSION RECEIVED
11/21/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/19/2016
IUAF
USE AMENDMENT FILED
11/11/2016
EISU
TEAS STATEMENT OF USE RECEIVED
11/11/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/08/2016
EX3G
SOU EXTENSION 3 GRANTED
07/07/2016
EXT3
SOU EXTENSION 3 FILED
05/23/2016
EEXT
SOU TEAS EXTENSION RECEIVED
05/23/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/16/2015
EX2G
SOU EXTENSION 2 GRANTED
12/15/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/11/2015
EXT2
SOU EXTENSION 2 FILED
11/19/2015
EEXT
SOU TEAS EXTENSION RECEIVED
11/19/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/02/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/02/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/23/2015
EX1G
SOU EXTENSION 1 GRANTED
05/21/2015
EXT1
SOU EXTENSION 1 FILED
05/21/2015
EEXT
SOU TEAS EXTENSION RECEIVED
05/21/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/25/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/30/2014
PUBO
PUBLISHED FOR OPPOSITION
09/30/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/10/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/26/2014
ALIE
ASSIGNED TO LIE
08/25/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/15/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/29/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/28/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/28/2014
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/03/2014
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/03/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/02/2014
GNRT
NON-FINAL ACTION E-MAILED
02/02/2014
CNRT
NON-FINAL ACTION WRITTEN
02/02/2014
DOCK
ASSIGNED TO EXAMINER
01/25/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/17/2013
NWAP
NEW APPLICATION ENTERED
10/14/2013
Continuous trademark protection
Get notified about every new filing that threatens Q QUIDEL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.